IDENTIFYING AND VALIDATING ONCOGENE-INDUCED MECHANISMS OF IMMUNOSUPPRESSION DOWNSTREAM OF THE ESRP1/FGFR2/KRAS AXIS TO IMPROVE IMMUNOTHERAPY
$530,941FY2022Defense Health AgencyDOD
Queensland University Of Technology, Brisbane
Queensland University Of Technology, Brisbane